PUBLISHER: QYResearch | PRODUCT CODE: 1052424
PUBLISHER: QYResearch | PRODUCT CODE: 1052424
Chronic obstructive pulmonary disease (COPD) and asthma devices are useful in inhalation therapy and assist in drug delivery by converting drug suspensions or solutions to aerosolized particles.
Market Analysis and Insights: Global COPD and Asthma Devices Market
Due to the COVID-19 pandemic, the global COPD and Asthma Devices market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Metered Dose Inhalers (MDI) accounting for % of the COPD and Asthma Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
The need for urgency in medication and portability of the drug delivery devices will drive the growth for COPD and Asthma devices.
Global COPD and Asthma Devices Scope and Segment
COPD and Asthma Devices market is segmented by Type and by Application. Players, stakeholders, and other participants in the global COPD and Asthma Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Segment by Application
By Company
By Region